Latest News

ACHIEVE LIFE SCIENCES: Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that additional analyses from the ORCA-1 Phase 2b trial will be presented today, Thursday, March 12th, at the SRNT Annual Meeting in New Orleans.

FOUNDATION FOR A SMOKE-FREE WORLD: Confusion about Quitting Options Impacts the Health of 1 Billion Smokers Globally

New Global Poll of Current and Former Tobacco Smokers and Harm Reduction Product Users Finds Broad Misperception of Nicotine as Potential Carcinogen, Expanding Gaps in Quit Attempts Across Countries

FDA: Requires new health warnings for cigarette packages and advertisements

New warnings with color images promote greater public understanding of negative health consequences of smoking

SEATCA: Philip Morris fined B130m for tax-dodging

Philip Morris (Thailand) Limited (PMTL) says it will appeal a Criminal Court ruling that it wrongly declared the price of cigarettes imported from Indonesia between 2002 and 2003.

PHILIP MORRIS INTERNATIONAL INC.: Announces Temporary Suspension of Operations at Manufacturing Technology Bologna

Philip Morris International believes there are adequate inventories of finished goods for an extended period

AMERICAN LUNG ASSOCIATION: COVID-19: What Those with Lung Disease Should Know

American Lung Association shares guidance for those with asthma, COPD, lung cancer and other lung diseases

Tobacco News Wire